GEODE CAPITAL MANAGEMENT, LLC - THRESHOLD PHARMACEUTICAL INC ownership

THRESHOLD PHARMACEUTICAL INC's ticker is THLD and the CUSIP is 885807206. A total of 36 filers reported holding THRESHOLD PHARMACEUTICAL INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of THRESHOLD PHARMACEUTICAL INC
ValueSharesWeighting
Q2 2017$155,000
-33.5%
395,464
-3.4%
0.00%
Q1 2017$233,000
+30.2%
409,477
+0.5%
0.00%
Q4 2016$179,000
-34.9%
407,569
+0.3%
0.00%
Q3 2016$275,000
+23.3%
406,297
+15.7%
0.00%
Q2 2016$223,000
+18.0%
351,290
-14.9%
0.00%
Q1 2016$189,000
-4.5%
412,921
-0.1%
0.00%
Q4 2015$198,000
-87.9%
413,239
+2.8%
0.00%
-100.0%
Q3 2015$1,636,000
+11.7%
402,018
+10.9%
0.00%0.0%
Q2 2015$1,465,000
+3.2%
362,666
+3.6%
0.00%0.0%
Q1 2015$1,420,000
+74.4%
349,974
+36.7%
0.00%
Q4 2014$814,000
-11.7%
256,003
+0.2%
0.00%
-100.0%
Q3 2014$922,000
-6.4%
255,535
+2.7%
0.00%0.0%
Q2 2014$985,000
-14.6%
248,775
+2.7%
0.00%0.0%
Q1 2014$1,153,000
+21.1%
242,326
+18.8%
0.00%0.0%
Q4 2013$952,000
+1.4%
204,058
+1.1%
0.00%0.0%
Q3 2013$939,000
-8.7%
201,874
+3.3%
0.00%0.0%
Q2 2013$1,028,000195,4660.00%
Other shareholders
THRESHOLD PHARMACEUTICAL INC shareholders Q2 2017
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 393,000$1,556,0001.48%
FORTALEZA ASSET MANAGEMENT INC/ 98,125$389,0000.18%
Rhenman & Partners Asset Management AB 121,537$481,0000.14%
Baker Brothers Advisors 1,826,358$7,232,0000.09%
Rotella Capital Management, Inc. 21,600$86,0000.07%
SSI INVESTMENT MANAGEMENT LLC 117,640$466,0000.04%
FEDERATED HERMES, INC. 2,391,400$9,470,0000.03%
TFS CAPITAL LLC 96,659$383,0000.03%
SMITH ASSET MANAGEMENT GROUP LP 191,038$757,0000.03%
FRANKLIN STREET ADVISORS INC /NC 28,000$111,0000.02%
View complete list of THRESHOLD PHARMACEUTICAL INC shareholders